First experiences of Sars-Cov-2 sequencing using Ion Genexus & Management of COVID -19 patients – What can biomarkers add.

Welcome to Thermo Fischer Scientifics session during State of the Art Covid-19

Titel: First experiences of Sars-Cov-2 sequencing using Ion Genexus
Speaker: Dr. Rob Schuurman, Ph.D., Head of Molecular Diagnostics, Department of Virology, University Medical Centre Utrecht, Netherlands

Rob Schuurman, PhD, is an associate Professor of Virology at the University Medical Center Utrecht and registered Medical Molecular Microbiologist. Rob is a lecturer in the field of Molecular Medical Microbiology. He is a coordinator / collaborator in several international research projects in Europe, USA and Africa, mainly focussing on HIV Drug Resistance and /or the development and application of molecular diagnostics. He is a member of the WHO HIVResNet laboratory working group. Rob has extensive experience in the rolling out of laboratory activities in LMIC and is actively involved in various global projects on quality control of molecular diagnostics.

Titel: Management of COVID -19 patients – What can biomarkers add
Speaker: Prof. Dr. Phillipp Schütz
Head of Department, Internal Medicine & Emergency Medicine, Cantonal Hospital in Aarau, Switzerland

Prof. Philipp Schuetz is a board-certified internist and endocrinologist. He obtained a Master of Public Health (MPH) at the Harvard School of Public Health Boston while doing clinical research at the Beth Israel Deaconess Medical Center (BIDMC). He currently has a professorship from the Swiss National Foundation and works clinically at the Medical University department at the Cantonal Hospital in Aarau in the emergency department and the Endocrine unit; and is in charge of clinical studies focusing on clinical nutrition (EFFORT), as well as on improved triage and management of patients throughout their hospital stay with the use of novel biomarkers.

Moderator: Dr Kordo Saeed
Dr Kordo Saeed is a consultant clinical microbiologist, currently working at the Department of Infection, at University Hospitals Southampton NHS Foundation Trust & an honorary senior lecturer at the University of Southampton School of medicine. He is the chair of the Rapid Diagnostics and Biomarker Working group of the International Society of Antimicrobial Chemotherapy (ISAC) the secretary for the Bone and Joint infection working group. He has published on Infection Control, Antibiotic Stewardship, Bone and Joint infections & Sepsis including the use of biomarkers as antibiotic stewardship tool.